Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Rheumatology|August 6, 2026
The Groove SignAna Serrano-Combarro, Jenna Guma, Sergio A Jimenez, et al.
European Journal of Internal Medicine|February 1, 2024
The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoidsAna Serrano-Combarro, Diana Prieto-Peña, Isabel Martínez-Rodríguez, et al.
Rheumatology (Oxford, England)|January 18, 2026
Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patientsAna Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutierrez, et al.
European Journal of Internal Medicine|June 11, 2026
Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patientsAna Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutierrez, et al.
International Journal of Molecular Sciences|November 13, 2025
A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising BiomarkersVerónica Pulito-Cueto, Belén Atienza-Mateo, Joao C Batista-Liz, et al.
Seminars in Arthritis and Rheumatism|March 21, 2025
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patientsBelén Atienza-Mateo, Ana Serrano-Combarro, Jesús Loarce Martos, et al.
RMD Open|May 18, 2026
Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER studyNatalia Mena-Vázquez, Marta Domínguez-Álvaro, María Gema Bonilla Hernán, et al.
Rheumatology (Oxford, England)|June 10, 2025
Baricitinib in rheumatoid arthritis-interstitial lung disease: national multicenter study of 72 patients and literature reviewAna Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutiérrez, et al.
Seminars in Arthritis and Rheumatism|July 27, 2024
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patientsMarta López-Maraver, Ana Serrano-Combarro, Belén Atienza-Mateo, et al.
Pageof 1